Isolation and characterization of plasma lipoproteins of common marmoset monkey. Comparison of effects of control and atherogenic diets

Arteriosclerosis : an Official Journal of the American Heart Association, Inc
D CrookR W Mahley

Abstract

This study examines the potential of the common marmoset monkey (Callithrix jacchus) to serve as a model for human lipoprotein metabolism and atherosclerosis. The lipoproteins of animals fed a low-fat, low-cholesterol diet and a high-fat (12% wt/wt lard), high-cholesterol (0.34% wt/wt) diet were characterized by the combination of sequential ultracentrifugation and Pevikon block electrophoresis. Based on chemical and physical properties, equivalents of human very low density lipoproteins (VLDL), low density lipoproteins (LDL), and high density lipoproteins (HDL), including and HDL-with apolipoprotein E subclass, were demonstrated. In control animals, whose plasma cholesterol concentration was 140.1 +/- 20.2 mg/dl (means +/- SD), approximately 40% of the plasma cholesterol was transported by LDL as compared with approximately 70% in humans. The cholesterol-fed marmosets segregated into two groups: hypo- and hyper-responders. The hyper-responders had plasma cholesterol levels of 450 to 970 mg/ml. The hypercholesterolemia was associated with elevated concentrations of VLDL, intermediate density lipoproteins, and LDL; in addition, these lipoproteins were enriched in cholesteryl esters relative to lipoproteins isolated from control ...Continue Reading

References

Jun 1, 1976·Experimental and Molecular Pathology·T B ClarksonL L Rudel
Jul 26, 1976·Biochemical and Biophysical Research Communications·C A Nelson, M D Morris
Jan 1, 1977·Annual Review of Biochemistry·J L Goldstein, M S Brown
Apr 1, 1975·Laboratory Animals·J P HearnM M Pilcher
Jul 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D CrookR W Mahley
Jan 1, 1985·Annals of the New York Academy of Sciences·R W WisslerM Bekermeier
Oct 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·S DreizenS Bernick
Sep 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·S DreizenS Bernick
Jan 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R E PitasR W Mahley
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J P KaneH E Paulus
Jan 1, 1982·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·Y C Ha, P J Barter
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Sep 1, 1991·Lipids·K Makino, A M Scanu
Sep 1, 1994·The Journal of Clinical Investigation·S H ZhangN Maeda
Feb 20, 2016·Scientific Reports·Mizuko OsakaMasayuki Yoshida
Jul 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D CrookR W Mahley
Jan 22, 2019·American Journal of Primatology·Corinna N RossSuzette D Tardif
Oct 13, 2018·Nutrients·Kenichiro TakanoToshisuke Morita
Mar 4, 2021·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Maud WeissNathalie Niederhoffer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.